Relapse Prevention After Recovery in Patients With Persistent Major Depressive Disorder-An Active Pursuit

被引:3
|
作者
Freeman, Marlene P. [1 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Clin Trials Network & Inst, Ammon Pinizzotto Ctr Womens Mental Hlth, Boston, MA 02115 USA
关键词
ANTIDEPRESSANTS;
D O I
10.1001/jamapsychiatry.2019.3637
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:231 / 232
页数:2
相关论文
共 50 条
  • [31] Prevention of Relapse With Maintenance Electroconvulsive Therapy in Elderly Patients With Major Depressive Episode
    Rapinesi, Chiara
    Kotzalidis, Georgios Demetrios
    Serata, Daniele
    Del Casale, Antonio
    Scatena, Paola
    Mazzarini, Lorenzo
    Caccia, Federica
    Brugnoli, Roberto
    Carbonetti, Paolo
    Fensore, Claudio
    Girardi, Paolo
    [J]. JOURNAL OF ECT, 2013, 29 (01) : 61 - 64
  • [32] Personalized relapse prediction in patients with major depressive disorder using digital biomarkers
    Srinivasan Vairavan
    Homa Rashidisabet
    Qingqin S. Li
    Seth Ness
    Randall L. Morrison
    Claudio N. Soares
    Rudolf Uher
    Benicio N. Frey
    Raymond W. Lam
    Sidney H. Kennedy
    Madhukar Trivedi
    Wayne C. Drevets
    Vaibhav A. Narayan
    [J]. Scientific Reports, 13
  • [33] Personalized relapse prediction in patients with major depressive disorder using digital biomarkers
    Vairavan, Srinivasan
    Rashidisabet, Homa
    Li, Qingqin S.
    Ness, Seth
    Morrison, Randall L.
    Soares, Claudio N.
    Uher, Rudolf
    Frey, Benicio N.
    Lam, Raymond W.
    Kennedy, Sidney H.
    Trivedi, Madhukar
    Drevets, Wayne C.
    Narayan, Vaibhav A.
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [34] Long-term efficacy of agomelatine, a novel antidepressant, in the prevention of relapse in out-patients with major depressive disorder
    Goodwin, G. M.
    Rouillon, F.
    Emsley, R.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S361 - S362
  • [35] Extended-release venlafaxine in relapse prevention for patients with major depressive disorder (vol 38, pg 249, 2004)
    Simon, JS
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2004, 38 (04) : 451 - 451
  • [36] The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder
    Dijkstra, Francis M.
    van de Loo, Aurora Jae
    Abdulahad, Smedra
    Bosma, Else R.
    Hartog, Mitch
    Huls, Hendrikje
    Kuijper, Dianne C.
    de Vries, Esther
    Solanki, Bhavna
    Singh, Jaskaran
    Aluisio, Leah
    Zannikos, Peter
    Stuurman, Frederik E.
    Jacobs, Gabriel E.
    Verster, Joris C.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2022, 36 (05) : 614 - 625
  • [37] CONCEPTUALIZATION AND RATIONALE FOR CONSENSUS DEFINITIONS OF TERMS IN MAJOR DEPRESSIVE DISORDER - REMISSION, RECOVERY, RELAPSE, AND RECURRENCE
    FRANK, E
    PRIEN, RF
    JARRETT, RB
    KELLER, MB
    KUPFER, DJ
    LAVORI, PW
    RUSH, AJ
    WEISSMAN, MM
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1991, 48 (09) : 851 - 855
  • [38] PREDICTORS OF RELAPSE INTO MAJOR DEPRESSIVE DISORDER IN A NONCLINICAL POPULATION
    CORYELL, W
    ENDICOTT, J
    KELLER, MB
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1991, 148 (10): : 1353 - 1358
  • [39] RELAPSE IN MAJOR DEPRESSIVE DISORDER - ANALYSIS WITH THE LIFE TABLE
    KELLER, MB
    SHAPIRO, RW
    LAVORI, PW
    WOLFE, N
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1982, 39 (08) : 911 - 915
  • [40] Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study
    Saragoussi, Delphine
    Touya, Maelys
    Haro, Josep Maria
    Jonsson, Bengt
    Knapp, Martin
    Botrel, Bastien
    Florea, Ioana
    Loft, Henrik
    Rive, Benoit
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 2151 - 2165